Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro

被引:177
作者
Goerke, C
Campana, S
Bayer, MG
Döring, G
Botzenhart, K
Wolz, C
机构
[1] Univ Tubingen, Allgemeine Hyg & Umwelthyg, D-72074 Tubingen, Germany
[2] 4base Lab GmbH Adv Mol Anal, Reutlingen, Germany
[3] Osped Meyer, Dipartimento Pediat Cesare Cocci, Florence, Italy
关键词
D O I
10.1128/IAI.68.3.1304-1311.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacteria possess a repertoire of distinct regulatory systems promoting survival in disparate environments. Under in vitro conditions it was demonstrated for the human pathogen Staphylococcus aureus that the expression of most virulence factors is coordinated by the global regulator agr. To monitor bacterial gene regulation in the host, we developed a method for direct transcript analysis from clinical specimens. Quantification of specific transcripts was performed by competitive reverse transcription-PCR, and results were normalized against the constitutively expressed gene for gyrase (gyr). Using sputum from cystic fibrosis (CP) patients infected with S. aureus we examined the transcription of the effector molecule RNAIII of agr, of spa (protein A), generally repressed by agr, and of hla (alpha-toxin), generally activated by agr. In the CF lung RNAIII was expressed poorly, indicating an inactive agr in vivo. Despite the low level of RNAIII expression, spa was detectable only in minute amounts and an irregular transcription of hla was observed in all sputum samples. After subculturing of patient strains agr deficient isolates and isolates with unusual expression profiles, i.e., not consistent with those obtained from prototypic strains, were observed. In conclusion, the agr activity seems to be nonessential in CF, and from the described expression pattern of spa and hla, other regulatory circuits aside from agr are postulated in vivo.
引用
收藏
页码:1304 / 1311
页数:8
相关论文
共 37 条
  • [11] INVOLVEMENT OF THE ACCESSORY GENE REGULATOR (AGR) IN EXPRESSION OF TYPE-5 CAPSULAR POLYSACCHARIDE BY STAPHYLOCOCCUS-AUREUS
    DASSY, B
    HOGAN, T
    FOSTER, TJ
    FOURNIER, JM
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 : 1301 - 1306
  • [12] Cystic fibrosis
    Davis, PB
    Drumm, M
    Konstan, MW
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (05) : 1229 - 1256
  • [13] STAPHYLOCOCCAL COAGULASE - MODE OF ACTION AND ANTIGENICITY
    DUTHIE, ES
    LORENZ, LL
    [J]. JOURNAL OF GENERAL MICROBIOLOGY, 1952, 6 (1-2): : 95 - 107
  • [14] ANTIBODIES TO STAPHYLOCOCCAL TEICHOIC-ACID AND ALPHA-TOXIN IN PATIENTS WITH CYSTIC-FIBROSIS
    ERICSSON, A
    GRANSTROM, M
    MOLLBY, R
    STRANDVIK, B
    [J]. ACTA PAEDIATRICA SCANDINAVICA, 1986, 75 (01): : 139 - 144
  • [15] Characterization of the sar locus and its interaction with agr in Staphylococcus aureus
    Heinrichs, JH
    Bayer, MG
    Cheung, AL
    [J]. JOURNAL OF BACTERIOLOGY, 1996, 178 (02) : 418 - 423
  • [16] SIMULTANEOUS IDENTIFICATION OF BACTERIAL VIRULENCE GENES BY NEGATIVE SELECTION
    HENSEL, M
    SHEA, JE
    GLEESON, C
    JONES, MD
    DALTON, E
    HOLDEN, DW
    [J]. SCIENCE, 1995, 269 (5222) : 400 - 403
  • [17] Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo
    Herbert, S
    Worlitzsch, D
    Dassy, B
    Boutonnier, A
    Fournier, JM
    Bellon, G
    Dalhoff, A
    Doring, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (02) : 431 - 438
  • [18] THE ROLE OF THE DELTA-LYSIN GENE (HLD) IN THE REGULATION OF VIRULENCE GENES BY THE ACCESSORY GENE REGULATOR (AGR) IN STAPHYLOCOCCUS-AUREUS
    JANZON, L
    ARVIDSON, S
    [J]. EMBO JOURNAL, 1990, 9 (05) : 1391 - 1399
  • [19] Cell density control of staphylococcal virulence mediated by an octapeptide pheromone
    Ji, GY
    Beavis, RC
    Novick, RP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) : 12055 - 12059
  • [20] Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis
    Kahl, B
    Herrmann, M
    Everding, AS
    Koch, HG
    Becker, K
    Harms, E
    Proctor, RA
    Peters, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04) : 1023 - 1029